Exelixis, Inc. (EXEL): Price and Financial Metrics

EXEL POWR Grades

• Value is the dimension where EXEL ranks best; there it ranks ahead of 94.7% of US stocks.
• The strongest trend for EXEL is in Value, which has been heading down over the past 179 days.
• EXEL's current lowest rank is in the Growth metric (where it is better than 19.49% of US stocks).

EXEL Stock Summary

• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.21 for EXELIXIS INC; that's greater than it is for merely 14.1% of US stocks.
• With a year-over-year growth in debt of 269.2%, EXELIXIS INC's debt growth rate surpasses 94.58% of about US stocks.
• In terms of volatility of its share price, EXEL is more volatile than merely 14.93% of stocks we're observing.
• If you're looking for stocks that are quantitatively similar to EXELIXIS INC, a group of peers worth examining would be UTSI, BCDA, LYRA, SABS, and BLDP.
• EXEL's SEC filings can be seen here. And to visit EXELIXIS INC's official web site, go to www.exelixis.com.

EXEL Valuation Summary

• In comparison to the median Healthcare stock, EXEL's price/sales ratio is 72.73% higher, now standing at 3.8.
• Over the past 243 months, EXEL's EV/EBIT ratio has gone up 35.6.

Below are key valuation metrics over time for EXEL.

EXEL Growth Metrics

Its year over year price growth rate is now at -14.86%.
• The year over year net income to common stockholders growth rate now stands at 360.14%.
• Its 4 year net income to common stockholders growth rate is now at 8238.51%.

The table below shows EXEL's growth in key financial areas (numbers in millions of US dollars).

EXEL's Quality Factors

• EXEL has a Quality Grade of B, ranking ahead of 93.02% of graded US stocks.
• EXEL's asset turnover comes in at 0.549 -- ranking 297th of 563 Business Services stocks.
• BBSI, QNST, and ROL are the stocks whose asset turnover ratios are most correlated with EXEL.

The table below shows EXEL's key quality metrics over time.